Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 13 studies | 28% ± 13% | |
classical monocyte | 12 studies | 28% ± 11% | |
macrophage | 9 studies | 21% ± 5% | |
monocyte | 7 studies | 21% ± 4% | |
conventional dendritic cell | 7 studies | 27% ± 14% | |
endothelial cell | 6 studies | 23% ± 4% | |
epithelial cell | 6 studies | 32% ± 13% | |
basal cell | 5 studies | 22% ± 5% | |
ciliated cell | 5 studies | 24% ± 8% | |
dendritic cell | 5 studies | 35% ± 18% | |
squamous epithelial cell | 4 studies | 34% ± 20% | |
myeloid cell | 4 studies | 25% ± 7% | |
plasmacytoid dendritic cell | 4 studies | 20% ± 4% | |
secretory cell | 3 studies | 23% ± 5% | |
natural killer cell | 3 studies | 17% ± 0% | |
goblet cell | 3 studies | 17% ± 1% | |
regulatory T cell | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 15368.67 | 1445 / 1445 | 100% | 97.06 | 183 / 183 |
pancreas | 100% | 8670.58 | 328 / 328 | 100% | 100.10 | 178 / 178 |
thymus | 100% | 12466.53 | 653 / 653 | 100% | 100.73 | 604 / 605 |
uterus | 100% | 12663.69 | 170 / 170 | 100% | 103.33 | 458 / 459 |
lung | 100% | 14001.35 | 578 / 578 | 100% | 90.46 | 1152 / 1155 |
skin | 100% | 12003.64 | 1808 / 1809 | 100% | 108.09 | 471 / 472 |
prostate | 100% | 11634.82 | 245 / 245 | 100% | 77.85 | 500 / 502 |
intestine | 100% | 13400.89 | 966 / 966 | 99% | 79.51 | 524 / 527 |
stomach | 100% | 9482.37 | 359 / 359 | 99% | 78.11 | 284 / 286 |
breast | 100% | 14315.21 | 459 / 459 | 99% | 95.84 | 1110 / 1118 |
kidney | 100% | 10195.43 | 89 / 89 | 99% | 94.70 | 894 / 901 |
bladder | 100% | 15336.62 | 21 / 21 | 99% | 87.43 | 500 / 504 |
ovary | 100% | 9853.35 | 180 / 180 | 99% | 57.45 | 426 / 430 |
adrenal gland | 100% | 12309.19 | 258 / 258 | 98% | 55.69 | 226 / 230 |
liver | 96% | 4545.07 | 218 / 226 | 95% | 47.08 | 385 / 406 |
brain | 91% | 4652.18 | 2403 / 2642 | 100% | 57.64 | 704 / 705 |
adipose | 100% | 13654.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14250.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 123.71 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 101.77 | 29 / 29 |
muscle | 100% | 32252.96 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 15293.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 92.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.37 | 1 / 1 |
heart | 99% | 10616.87 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 12742.71 | 921 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051014 | Biological process | actin filament severing |
GO_0051016 | Biological process | barbed-end actin filament capping |
GO_0030239 | Biological process | myofibril assembly |
GO_0008154 | Biological process | actin polymerization or depolymerization |
GO_0005903 | Cellular component | brush border |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005925 | Cellular component | focal adhesion |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | FLII |
Protein name | Protein flightless-1 homolog FLII actin remodeling protein FLII actin remodeling protein (Protein flightless-1 homolog) |
Synonyms | FLIL |
Description | FUNCTION: May play a role as coactivator in transcriptional activation by hormone-activated nuclear receptors (NR) and acts in cooperation with NCOA2 and CARM1. Involved in estrogen hormone signaling. Involved in early embryonic development (By similarity). May play a role in regulation of cytoskeletal rearrangements involved in cytokinesis and cell migration, by inhibiting Rac1-dependent paxillin phosphorylation. . |
Accessions | A0A1W2PP30 ENST00000577485.1 Q13045 ENST00000577626.1 A0A1W2PR04 J3KS54 ENST00000639036.1 K7EP37 ENST00000327031.9 [Q13045-1] A0A1W2PPD5 ENST00000639299.1 ENST00000581858.5 ENST00000639967.1 ENST00000640276.1 ENST00000638812.1 [Q13045-3] ENST00000628188.1 K7EP27 J3KS39 ENST00000578558.5 A0A1W2PQI6 A0A1W2PS03 ENST00000545457.6 [Q13045-2] ENST00000578101.5 ENST00000488932.5 ENST00000640595.1 J3QLR6 ENST00000638404.1 [Q13045-2] K7EQZ7 ENST00000581401.1 ENST00000581349.5 ENST00000579294.5 [Q13045-3] ENST00000638207.2 [Q13045-1] ENST00000639646.1 J3QQU5 A0A1W2PNT9 ENST00000638982.1 ENST00000638637.1 ENST00000473425.2 A0A1W2PPN0 J3QQQ2 ENST00000638796.1 A0A1W2PSB1 J3KT47 ENST00000577398.6 ENST00000639125.1 ENST00000640412.1 K7EJJ7 |